The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Adamyan L.V.
Russian University of Medicine;
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Pivazyan L.G.
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Stepanian A.A.
Academy of Women’s Health and Endoscopic Surgery
Experimental modeling, prevention, and treatment of endometriosis-associated adhesion formation in NIH/3T3 fibroblast cell line using bovhyaluronidase azoximer (in vitro)
Journal: Russian Journal of Human Reproduction. 2024;30(6): 61‑72
Views: 473
Downloaded: 37
To cite this article:
Adamyan LV, Pivazyan LG, Mailova KS, Peshkova YuO, Stepanian AA. Experimental modeling, prevention, and treatment of endometriosis-associated adhesion formation in NIH/3T3 fibroblast cell line using bovhyaluronidase azoximer (in vitro). Russian Journal of Human Reproduction.
2024;30(6):61‑72. (In Russ.)
https://doi.org/10.17116/repro20243006161
Endometriosis is a gynecological disease characterized by the presence of tissue that is morphologically and functionally similar to the endometrium, but located outside the uterine cavity, with a chronic and recurrent course. According to literature, endometriosis affects approximately 10% of women of reproductive age worldwide. Fibrosis plays a key role in both the pathogenesis and progression of endometriosis, as well as in the manifestation of its symptoms. The fibrotic process is initiated by inflammation, which is accompanied by the release of cytokines, such as TGF-β1, IL-17, and others, leading to the activation of fibroblasts and their transformation into myofibroblasts. Myofibroblasts contribute to the excessive production of collagen, hyaluronic acid, and other components of the extracellular matrix, resulting in the formation of fibrous tissue and adhesions. This mechanism underlies the progression of endometriosis-associated adhesion processes, exacerbating the clinical picture of the disease, causing pain, dyspareunia, bleeding, organ dysfunction, infertility, and overall reduced quality of life. The study evaluated the effectiveness of bovhyaluronidase azoximer (an enzyme preparation that is a modified form of hyaluronidase, with azoximer being a biopolymer that enhances the pharmacological properties of hyaluronidase by increasing its stability and duration of action in the body) in both the prevention and treatment of endometriosis-associated adhesion processes. An in vitro cellular model was used for this purpose. Thus, in a cell model (in vitro), it was demonstrated that bovhyaluronidase azoximer inhibits key profibrotic mechanisms induced by transforming growth factor-β1 (TGF-β1), such as collagen I expression, metabolic activity, and myofibroblast migration, which confirms its antifibrotic potential. The application of bovhyaluronidase azoximer suppressed the metabolic activity and migration of myofibroblasts, confirming its antifibrotic potential. These results demonstrate promising prospects for the prevention and targeted therapy of fibrotic changes in endometriosis, as well as reducing the risk of adhesion formation, opening new possibilities for the comprehensive treatment of the disease.
Authors:
Adamyan L.V.
Russian University of Medicine;
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Pivazyan L.G.
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Stepanian A.A.
Academy of Women’s Health and Endoscopic Surgery
Received:
08.10.2024
Accepted:
31.10.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.